EVIDENCE 360: RWE in Pricing & Reimbursement of Biosimilars and Biologics
The landscape of Real-World Evidence (RWE) is evolving rapidly, shaping the future of healthcare decision-making, market access, and pricing strategies. If you are involved in the pharmaceutical, biotech, academic, or regulatory sectors, the Real-World Evidence Summit in Germany, also known as RWE E